Transparency throughout the healthcare system could produce safer care, better outcomes, and reduced costs of care, according to a new report from the National Patient Safety Foundation's Lucian Leape Institute.
Transparency throughout the healthcare system could produce safer care, better outcomes, and more trust among involved parties, according to a new report from the National Patient Safety Foundation’s Lucian Leape Institute.
The Shining a Light: Safer Health Care Through Transparency report addresses 4 domains where the open exchange of information is necessary to improve safety and provides more than 3 dozen recommendations for clinicians, healthcare executives, and policy makers. These recommendations address issues such as disclosure of conflicts of interest, shared decision making with patients, and development of core competencies for communicating medical errors and quality measures to various other stakeholders.
“We hope this report will help convince people that transparency is not only the right thing to do, but that it will lead to improved outcomes, fewer errors, more satisfied patients, and reduced costs of care,” Robert M. Wachter, MD, associate chair of the department of medicine at University of California, San Francisco, said in a statement.
Dr Wachter and Gary Kaplan, MD, FACMPE, chief executive officer, Virginia Mason Health System, served as co-chairs for this project. Both are members of the Lucian Leape Institute.
The 4 domains of transparency that the report focused on were:
“Transparency has been largely overlooked as a patient safety tool, in part because it requires a foundation of a safety culture and strong organizational leadership,” Gary Kaplan, MD, FACMPE, chief executive officer, Virginia Mason Health System, said. “The barriers are not necessarily easy to overcome, but we will never truly achieve safe patient care without improvements in transparency in each of the domains we cite.”
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More